HB 1087

Indiana House bill in Session 2026.

Status: in_committee. Latest action: January 5, 2026.

Overdose reversal medication.

Bill ID IN-2026-HB-1087
Session 2026
Status in_committee
Committee Public Health
House in_committee 2026-01-05
Summary

Provides that, subject to available funding, the division of mental health and addiction may develop an application to provide funds to a school corporation or school maintained by a school corporation to obtain a federal Food and Drug Administration approved opioid overdose reversal medication. Provides that the state health commissioner shall issue a statewide standing order, prescription, or protocol for a federal Food and Drug Administration approved opioid overdose reversal medication for each public school or school corporation.

Sponsor
Mike Andrade
Official Source Back to Bills
Actions Timeline
Date Event Detail
2026-01-05 Introduced Bill introduced
2026-01-05 Status in_committee
2026-01-05 Latest Action First reading: referred to Committee on Public Health
More Bills From This Sponsor
More Bills In This Topic
Related Topics
Same Topic Bills From Other States